Prescribed Medical Conditions
Medical Grade Cannabis can improve the state and well-being of patients suffering from a range of medical conditions unmet by current medical treatments based on clinical research as well as eight years of treating thousands of patients a month by Cann Pharmaceutical in Israel.
Medical Grade Cannabis brings renewed hope to patients suffering the plight of diseases and medical conditions including cancer, epilepsy, copd, severe pain conditions, HIV/Aids, Parkinson’s and Multiple Sclerosis.
In Israel, the Ministry of Health has approved the use of better™’s MGC treatments, including for a number of medical conditions such as:
- Cancer & Palliative Care
- Chronic Pain
- PTSD (Post Traumatic Stress Disorder)
- MS (Multiple Sclerosis)
- Crohn’s Disease
- Ulcerative Colitis
- Cachexia (Wasting Syndrome)
- Tourette Syndrome
- Terminal Illnesses (life expectancy up to six months)
- Cluster Headaches
Medical Grade Cannabis can also improve the state and wellbeing of patients suffering from:
- Severe Arthritis
- Post traumatic stress disorder (PTSD)
- Cerebral Palsy
- Spinal cord injuries
- Severe Migraines
- Crohn’s disease
Get better, register now
As better™ Medical Grade Cannabis treatments and products are gaining increasing recognition in the worldwide market, better™ stands at the forefront of the industry in Israel, Europe and now Australia.
Register with Cann Pharmaceutical Australia and better™ to stay in touch with latest news, clinical studies and advancements regarding our better™ Medical Grade Cannabis.
Approved Cultivation & Manufacturing License:
- Czech Rep.
Applied Cutlivation License for: